Vanguard Group’s ATAI Life Sciences ATAI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $957K | Buy |
436,932
+47,749
| +12% | +$105K | ﹤0.01% | 3755 |
|
|
2025
Q1 | $529K | Sell |
389,183
-11,377
| -3% | -$15.5K | ﹤0.01% | 3872 |
|
|
2024
Q4 | $533K | Sell |
400,560
-7,124
| -2% | -$9.48K | ﹤0.01% | 3934 |
|
|
2024
Q3 | $473K | Sell |
407,684
-3,800
| -0.9% | -$4.41K | ﹤0.01% | 3983 |
|
|
2024
Q2 | $547K | Sell |
411,484
-2,292
| -0.6% | -$3.05K | ﹤0.01% | 3975 |
|
|
2024
Q1 | $815K | Buy |
413,776
+4,314
| +1% | +$8.5K | ﹤0.01% | 3880 |
|
|
2023
Q4 | $577K | Sell |
409,462
-113,729
| -22% | -$160K | ﹤0.01% | 3989 |
|
|
2023
Q3 | $675K | Buy |
523,191
+3,297
| +0.6% | +$4.25K | ﹤0.01% | 3965 |
|
|
2023
Q2 | $894K | Sell |
519,894
-3,578
| -0.7% | -$6.15K | ﹤0.01% | 3935 |
|
|
2023
Q1 | $947K | Buy |
523,472
+30,843
| +6% | +$55.8K | ﹤0.01% | 3937 |
|
|
2022
Q4 | $1.31M | Buy |
492,629
+8,062
| +2% | +$21.4K | ﹤0.01% | 3816 |
|
|
2022
Q3 | $1.6M | Buy |
484,567
+3,807
| +0.8% | +$12.6K | ﹤0.01% | 3841 |
|
|
2022
Q2 | $1.75M | Buy |
+480,760
| New | +$1.75M | ﹤0.01% | 3860 |
|